ACE and metabolic syndrome: Patients with increased cIMT were older and had higher body mass index (BMI), hypertension, diabetes, and dyslipidemia and took more antiplatelet agents, angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB), and statins (Table 1).